4-Acetoxy-MiPT

4-Acetoxy-MiPT
Names
	Preferred IUPAC name 3-{2-[Methyl(propan-2-yl)amino]ethyl}-1H-indol-4-yl acetate
	Other names Mipracetin
Identifiers
CAS Number	1024612-25-6 ;
3D model (JSmol)	Interactive image;
ChemSpider	23976075 ;
PubChem CID	46783587;
UNII	SS93IMV779 ;
CompTox Dashboard (EPA)	DTXSID70676236 ;
	InChI InChI=1S/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3 Key: CIDMXLOVFPIHDS-UHFFFAOYSA-N ; InChI=1/C16H22N2O2/c1-11(2)18(4)9-8-13-10-17-14-6-5-7-15(16(13)14)20-12(3)19/h5-7,10-11,17H,8-9H2,1-4H3 Key: CIDMXLOVFPIHDS-UHFFFAOYAP;
	SMILES CC(N(CCC1=CNC2=C1C(OC(C)=O)=CC=C2)C)C;
Properties
Chemical formula	C16H22N2O2
Molar mass	274.364 g·mol−1
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). verify (what is ?) Infobox references

4-AcO-MiPT (4-acetoxy-N-methyl-N-isopropyltryptamine or mipracetin) is a psychedelic tryptamine. It is closely related to O-acetylpsilocin and MiPT.

There is very little information on the human pharmacology or toxicity of 4-AcO-MiPT, although analytical methods have been developed for its detection.[1][2]

Drug prohibition laws

Sweden

Sveriges riksdags health ministry Statens folkhälsoinstitut classified 4-AcO-MiPT as "health hazard" under the act Lagen om förbud mot vissa hälsofarliga varor (translated Act on the Prohibition of Certain Goods Dangerous to Health) as of Nov 1, 2005, in their regulation SFS 2005:733 listed as 4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT), making it illegal to sell or possess.[3]

References

TAKAHASHI, M; NAGASHIMA, M; SUZUKI, J; SETO, T; YASUDA, I; YOSHIDA, T (15 February 2009). "Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry". Talanta. 77 (4): 1245–1272. doi:10.1016/j.talanta.2008.07.062. PMID 19084633.
Noorizadeh, Hadi; Farmany, Abbas; Noorizadeh, Mehrab (20 September 2011). "Application of GA–KPLS and L–M ANN calculations for the prediction of the capacity factor of hazardous psychoactive designer drugs". Medicinal Chemistry Research. 21 (9): 2680–2688. doi:10.1007/s00044-011-9794-y. S2CID 16413083.
"Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor" (PDF) (in Swedish). 6 October 2005. Archived from the original (PDF) on 26 June 2021.

External links

Erowid 4-AcO-MiPT Vault
Erowid's online version of TiHKAL, a book about Tryptamines

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.

[1] TAKAHASHI, M; NAGASHIMA, M; SUZUKI, J; SETO, T; YASUDA, I; YOSHIDA, T (15 February 2009). "Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography–mass spectrometry". Talanta. 77 (4): 1245–1272. doi:10.1016/j.talanta.2008.07.062. PMID 19084633.

[2] Noorizadeh, Hadi; Farmany, Abbas; Noorizadeh, Mehrab (20 September 2011). "Application of GA–KPLS and L–M ANN calculations for the prediction of the capacity factor of hazardous psychoactive designer drugs". Medicinal Chemistry Research. 21 (9): 2680–2688. doi:10.1007/s00044-011-9794-y. S2CID 16413083.

[3] "Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor" (PDF) (in Swedish). 6 October 2005. Archived from the original (PDF) on 26 June 2021.